MedPath

Probenecid

Generic Name
Probenecid
Drug Type
Small Molecule
Chemical Formula
C13H19NO4S
CAS Number
57-66-9
Unique Ingredient Identifier
PO572Z7917
Background

The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.

Indication

For the reduction of serum uric acid concentrations in chronic gouty arthritis and tophaceous gout in patients with frequent disabling gout attacks. Has also been effectively used to promote uric acid excretion in hyperuricemia secondary to the administration of thiazide and related diuretics.

Associated Conditions
Bacterial Infections, Chronic Gouty Arthritis, Elevated Serum Uric Acid, Gout Chronic, Hyperuricemia, Infection

The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Phase 2
Completed
Conditions
Cytomegalovirus Retinitis
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Gilead Sciences
Target Recruit Count
48
Registration Number
NCT00002437
Locations
🇬🇧

Charing Cross and Westminster Med School, London SW 10, United Kingdom

🇺🇸

Mount Zion Med Ctr, San Francisco, California, United States

🇺🇸

Univ of North Carolina Hosps, Chapel Hill, North Carolina, United States

and more 6 locations

A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease

Phase 1
Withdrawn
Conditions
Cytomegalovirus Infections
Cytomegalovirus Retinitis
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Registration Number
NCT00000881

A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients

Not Applicable
Completed
Conditions
HIV Infections
Leukoencephalopathy, Progressive Multifocal
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
24
Registration Number
NCT00000945
Locations
🇺🇸

Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States

🇺🇸

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco, California, United States

🇺🇸

Univ of Alabama at Birmingham, Birmingham, Alabama, United States

and more 16 locations
© Copyright 2025. All Rights Reserved by MedPath